Donor origin of hematopoiesis after a case of allogeneic transplantation with cryopreserved marrow.
In allogeneic marrow transplantation (BMT), fresh donor marrow is generally given like a simple transfusion immediately after collection. Cryopreservation, on the other hand, is extensively used in autologous marrow transplantation (ABMT). However, there could be a few instances in which donor marrow should be cryopreserved for later reinfusion mainly because of the donor's inability, for logistic or medical reasons, to undergo marrow harvesting immediately prior to transplantation. We wish to describe a case of ALL transplanted with donor harvested earlier and cryopreserved. The bone marrow was cryopreserved with 10% DMSO in a controlled rate freezer and stored for 1 month in liquid nitrogen. The VNTR (variation number tandem repeat) technique was used to demonstrate the donor origin of blood cells. Hematological reconstitution was rapidly achieved and we demonstrated the allogeneic origin of the recipient's blood cells. We confirm the possibility of using cryopreserved marrow stem cells for BMT. Cryopreservation of stem cells from other origin may also find a useful application in BMT.
Benini
C
C
Institute of Hematology L. e A. Seràgnoli, St. Orsola, University Hospital, Bologna, Italy.
Bandini
G
G
Motta
M R
MR
Belardinelli
A R
AR
Calori
E
E
Rizzi
S
S
Martinelli
G
G
Rosti
G
G
Trabetti
E
E
Pignatti
P
P
D000328:Adult; D016026:Bone Marrow Transplantation; D015925:Cryopreservation; D006410:Hematopoiesis / Q000502:physiology*; D006801:Humans; D008297:Male; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000097:blood / Q000628:therapy*; D014019:Tissue Donors; D014184:Transplantation, Homologous